TurnerTrends Stock Rating Report for BDSI
Data valid for week beginning July 21, 2008
|
BDSI [News]
|
BioDelivery Sciences International Inc
|
Company Profile
"BioDelivery Sciences International, Inc. operates as a specialty biopharmaceutical company in the United States. Its patented drug delivery technologies include BEMA drug delivery technology and Bioral cochleate drug delivery technology. The company, using its drug delivery technologies, develops and commercializes formulations of proven therapeutics for acute conditions occurring in cancer and surgical patients in the areas of pain and fungal infections. Its lead product includes BEMA Fentanyl for the treatment of breakthrough cancer pain. The company's lead Bioral formulation is an encochleated version of Amphotericin B, an anti-fungal treatment for systemic fungal infections. Its Bioral formulation for the intranasal administration of Amphotericin B to treat chronic rhinosinusitis is in initial in vitro studies. The company's products-formulations also include BEMA Buprenorphine, which is in Phase I clinical trial for moderate and severe pain- and BEMA Zolpidem, which is in pre-clinical stage for insomnia. It is also developing Emezine for the treatment of nausea and vomiting. The company was founded in 1997 and is based in Raleigh, North Carolina."
|
Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.
|
|
|
Want to take a more "hands off" approach to investing with TurnerTrends? Try our managed accounts and hedge fund at Sabinal Capital Investments
|
|
Latest News
| Wed, 11 Jun 2008 10:03:59 Etc/GMT | BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K/A, Changes in Registrant's Certifying Accountant, Financial (EDGAR Online) | | Fri, 6 Jun 2008 21:10:36 Etc/GMT | BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Change in D (EDGAR Online) | | Fri, 30 May 2008 21:01:08 Etc/GMT | BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibit (EDGAR Online) | | Fri, 30 May 2008 11:00:00 Etc/GMT | Phase III Data on BEMA(TM) Fentanyl to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting (Business Wire) | | Thu, 22 May 2008 13:29:38 Etc/GMT | BIODELIVERY SCIENCES INTERNATIONAL INC Financials (EDGAR Online Financials) | | Thu, 15 May 2008 20:25:44 Etc/GMT | BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report (EDGAR Online) | | Thu, 8 May 2008 21:05:32 Etc/GMT | BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibit (EDGAR Online) | | Thu, 8 May 2008 12:00:00 Etc/GMT | BEMA(TM) Fentanyl Phase III Data Demonstrating Efficacy and Tolerability to be Presented at American Pain Society Annual Meeting (Business Wire) | | Mon, 5 May 2008 11:00:00 Etc/GMT | BioDelivery Sciences Presenting Phase III Data on BEMA(TM) Fentanyl at American Pain Society Meeting (Business Wire) | | Fri, 7 Mar 2008 21:46:54 Etc/GMT | BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 10-K, Annual Report (EDGAR Online) | | Mon, 14 Jan 2008 22:15:34 Etc/GMT | BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Financial Statements and Exhibits (EDGAR Online) | | Wed, 21 Nov 2007 22:25:46 Etc/GMT | BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 10KSB/A, Annual Report (EDGAR Online) | | Wed, 14 Nov 2007 11:12:40 Etc/GMT | BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Non-Reliance on Previous Financials, Audits or Interim Rev (EDGAR Online) | | Fri, 2 Nov 2007 20:59:03 Etc/GMT | BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online) | | Fri, 14 Sep 2007 21:19:07 Etc/GMT | BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibit (EDGAR Online) | | Fri, 14 Sep 2007 19:51:02 Etc/GMT | Friday's Health Winners & Losers (at TheStreet.com) | | Wed, 12 Sep 2007 21:14:39 Etc/GMT | BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a (EDGAR Online) | | Mon, 10 Sep 2007 21:26:40 Etc/GMT | BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of (EDGAR Online) | | Wed, 5 Sep 2007 19:55:54 Etc/GMT | Wednesday's Health Winners & Losers (at TheStreet.com) | | Tue, 14 Aug 2007 15:47:51 Etc/GMT | BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 10QSB, Quarterly Report (EDGAR Online) | News provided by Yahoo! Finance |
|
